Does INFLIXIMAB Cause Therapeutic response shortened? 1,231 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 1,231 reports of Therapeutic response shortened have been filed in association with INFLIXIMAB (Renflexis). This represents 0.9% of all adverse event reports for INFLIXIMAB.
1,231
Reports of Therapeutic response shortened with INFLIXIMAB
0.9%
of all INFLIXIMAB reports
9
Deaths
260
Hospitalizations
How Dangerous Is Therapeutic response shortened From INFLIXIMAB?
Of the 1,231 reports, 9 (0.7%) resulted in death, 260 (21.1%) required hospitalization, and 5 (0.4%) were considered life-threatening.
Is Therapeutic response shortened Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INFLIXIMAB. However, 1,231 reports have been filed with the FAERS database.
What Other Side Effects Does INFLIXIMAB Cause?
Off label use (34,801)
Drug ineffective (33,738)
Condition aggravated (16,616)
Rheumatoid arthritis (16,251)
Pain (15,061)
Fatigue (13,473)
Arthralgia (13,441)
Infusion related reaction (12,946)
Product use issue (12,752)
Drug intolerance (11,173)
What Other Drugs Cause Therapeutic response shortened?
DUPILUMAB (6,720)
ADALIMUMAB (2,597)
INFLIXIMAB-DYYB (1,837)
SECUKINUMAB (1,097)
RISANKIZUMAB-RZAA (1,089)
CARBIDOPA\LEVODOPA (1,027)
ONABOTULINUMTOXINA (907)
ERENUMAB-AOOE (805)
CERTOLIZUMAB PEGOL (687)
NALTREXONE (658)
Which INFLIXIMAB Alternatives Have Lower Therapeutic response shortened Risk?
INFLIXIMAB vs INFLIXIMAB-ABDA
INFLIXIMAB vs INFLIXIMAB-AXXQ
INFLIXIMAB vs INFLIXIMAB-DYYB
INFLIXIMAB vs INFLIXIMAB-QBTX
INFLIXIMAB vs INFLIXIMAB, RECOMBINANT